Sign up for the Immunotherapy Insiders Newsletter to get actionable advice and exclusive deals direct to your inbox.
Jurkat CD19-, eGFP
|Description||The Jurkat cell line (originally called JM) was established in the late 1970s from the peripheral blood of a 14-year-old boy with T cell leukemia. Jurkat cells which are CD19-negative are generated using lentiviral GFP transduction (CD19- eGFP cells). These cells can be used as a negative control target cells for CAR-T with CD19-CAR-T cells.|
|Concentration||1 x 10^6 cells/ml|
|Emission maximum||509 nm|
|Excitation maximum||489 nm|
|Shipping Information||This product will ship in a box containing dry ice at a temperature of -80°C. Learn More|